# Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

> **NCT03792919** · PHASE4 · RECRUITING · sponsor: **Humanity & Health Medical Group Limited** · enrollment: 2000 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Stop current treatment (anti-HBV neucleos(t)ides)
- **DRUG:** Keep current treatment (anti-HBV neucleos(t)ides)

## Key facts

- **NCT ID:** NCT03792919
- **Lead sponsor:** Humanity & Health Medical Group Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792919, "Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03792919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*